Published in Med J Aust on June 05, 2006
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis (2007) 3.98
Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol (2006) 1.43
Evolution and diversity of community-associated methicillin-resistant Staphylococcus aureus in a geographical region. BMC Microbiol (2011) 1.41
Carriage of community-associated methicillin-resistant Staphylococcus aureus in a cohort of infants in southern Israel: risk factors and molecular features. J Clin Microbiol (2009) 1.09
Population dynamics of methicillin-susceptible and -resistant Staphylococcus aureus in remote communities. J Antimicrob Chemother (2009) 0.96
Comparison of flocked and rayon swabs for detection of nasal carriage of Staphylococcus aureus among pathology staff members. J Clin Microbiol (2010) 0.94
Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care units. J Clin Microbiol (2010) 0.91
Life-threatening infection due to community-acquired methicillin-resistant Staphylococcus aureus: case report and review. Eur J Pediatr (2009) 0.84
Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton-Valentine leukocidin. Eur J Clin Microbiol Infect Dis (2010) 0.83
Skin infections among Indigenous Australians in an urban setting in far North Queensland. Epidemiol Infect (2007) 0.81
Whole genome sequencing to investigate a putative outbreak of the virulent community-associated methicillin-resistant Staphylococcus aureus ST93 clone in a remote Indigenous community. Microb Genom (2016) 0.75
Molecular epidemiology of Panton-Valentine Leukocidin-positive community-acquired methicillin resistant Staphylococcus aureus isolates in pastoral communities of rural south western Uganda. BMC Infect Dis (2017) 0.75
Antiretrovirals as antimalarial agents. J Infect Dis (2004) 3.60
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol (2009) 2.94
Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol (2006) 2.89
Assessment of the anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis (2011) 2.81
Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev (2007) 2.50
A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis (2012) 2.28
A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis (2012) 2.09
Genetic diversity among community methicillin-resistant Staphylococcus aureus strains causing outpatient infections in Australia. J Clin Microbiol (2004) 2.03
Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int J Parasitol (2009) 1.96
Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms. J Med Microbiol (2006) 1.87
Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis (2009) 1.87
A comparison of the sensitivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-transmitted helminths. PLoS Negl Trop Dis (2011) 1.81
Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus. J Infect Dis (2012) 1.78
The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ (2009) 1.77
Treatment of Acinetobacter infections. Clin Infect Dis (2010) 1.76
Identification and interrogation of highly informative single nucleotide polymorphism sets defined by bacterial multilocus sequence typing databases. J Med Microbiol (2004) 1.72
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. Antimicrob Agents Chemother (2006) 1.72
Permethrin and ivermectin for scabies. N Engl J Med (2010) 1.71
Failure of current cefepime breakpoints to predict clinical outcomes of bacteremia caused by gram-negative organisms. Antimicrob Agents Chemother (2007) 1.66
Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis (2009) 1.59
Human infection with Photorhabdus asymbiotica: an emerging bacterial pathogen. Microbes Infect (2004) 1.51
Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol (2006) 1.43
Immune reconstitution syndrome to Strongyloides stercoralis syndrome: authors' response. AIDS (2007) 1.42
Health care contacts in the year before suicide death. J Gen Intern Med (2014) 1.40
Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One (2011) 1.35
Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot Cell (2009) 1.33
Effect of hookworm infection on wheat challenge in celiac disease--a randomised double-blinded placebo controlled trial. PLoS One (2011) 1.30
A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis (2010) 1.28
A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis (2012) 1.27
Insights into Acinetobacter baumannii pathogenicity. IUBMB Life (2011) 1.26
A research agenda for helminth diseases of humans: towards control and elimination. PLoS Negl Trop Dis (2012) 1.26
Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis (2013) 1.23
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy. Trans R Soc Trop Med Hyg (2006) 1.23
Antimalarial activity of sera from subjects taking HIV protease inhibitors. AIDS (2007) 1.23
High-resolution DNA melt curve analysis of the clustered, regularly interspaced short-palindromic-repeat locus of Campylobacter jejuni. Appl Environ Microbiol (2007) 1.22
Emergence of IMP-4 metallo-beta-lactamase in a clinical isolate from Australia. J Antimicrob Chemother (2004) 1.19
Genotyping of Campylobacter jejuni using seven single-nucleotide polymorphisms in combination with flaA short variable region sequencing. J Med Microbiol (2006) 1.17
Epidemiological profile of linezolid-resistant coagulase-negative staphylococci. Clin Infect Dis (2006) 1.16
The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis (2011) 1.16
bla(SHV) Genes in Klebsiella pneumoniae: different allele distributions are associated with different promoters within individual isolates. Antimicrob Agents Chemother (2005) 1.15
Phylogenetically distinct Staphylococcus aureus lineage prevalent among indigenous communities in northern Australia. J Clin Microbiol (2009) 1.14
Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3. J Clin Microbiol (2012) 1.13
Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog (2012) 1.13
High-resolution melting analysis of the spa repeat region of Staphylococcus aureus. Clin Chem (2008) 1.11
Laboratory demonstration of a prozone-like effect in HRP2-detecting malaria rapid diagnostic tests: implications for clinical management. Malar J (2011) 1.10
Scratching the itch: new tools to advance understanding of scabies. Trends Parasitol (2012) 1.10
Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies. Expert Rev Anti Infect Ther (2013) 1.10
Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One (2011) 1.10
Experimentally induced blood stage malaria infection as a tool for clinical research. Trends Parasitol (2012) 1.09
A tractable experimental model for study of human and animal scabies. PLoS Negl Trop Dis (2010) 1.09
Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents (2010) 1.08
Factors associated with the isolation of Nontuberculous mycobacteria (NTM) from a large municipal water system in Brisbane, Australia. BMC Microbiol (2013) 1.07
Inter-country transfer of Gram-negative organisms carrying the VIM-4 and OXA-58 carbapenem-hydrolysing enzymes. J Antimicrob Chemother (2006) 1.07
OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother (2006) 1.07
Systematic derivation of marker sets for staphylococcal cassette chromosome mec typing. Antimicrob Agents Chemother (2007) 1.06
Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM. J Clin Microbiol (2013) 1.04
How complete are E-codes in commercial plan claims databases? Pharmacoepidemiol Drug Saf (2014) 1.03
The RpoB H₄₈₁Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis (2012) 1.02
Fingerprinting of Campylobacter jejuni by using resolution-optimized binary gene targets derived from comparative genome hybridization studies. Appl Environ Microbiol (2006) 1.02
Application of in vitro anthelmintic sensitivity assays to canine parasitology: detecting resistance to pyrantel in Ancylostoma caninum. Vet Parasitol (2008) 1.02
Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Antimicrob Agents Chemother (2009) 1.01
Mycobacterium lentiflavum in drinking water supplies, Australia. Emerg Infect Dis (2011) 1.00
Photorhabdus asymbiotica, a pathogen emerging on two continents that proves that there is no substitute for a well-trained clinical microbiologist. J Clin Microbiol (2005) 1.00
Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep (2013) 0.99
The functions of Mediator in Candida albicans support a role in shaping species-specific gene expression. PLoS Genet (2012) 0.99
Unique vascular phenotypes following over-expression of individual VEGFA isoforms from the developing lens. Angiogenesis (2006) 0.99
Case report: nitazoxanide for treatment of refractory bony hydatid disease. Am J Trop Med Hyg (2009) 0.99
Rhizomycosis infection in the basal ganglia. Arch Neurol (2007) 0.98
The complete genome and phenome of a community-acquired Acinetobacter baumannii. PLoS One (2013) 0.97
Oxantel pamoate-albendazole for Trichuris trichiura infection. N Engl J Med (2014) 0.97
HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother (2011) 0.96
A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. J Infect Dis (2014) 0.96
Mitochondrial sorting and assembly machinery subunit Sam37 in Candida albicans: insight into the roles of mitochondria in fitness, cell wall integrity, and virulence. Eukaryot Cell (2012) 0.95
Increased transcription of Glutathione S-transferases in acaricide exposed scabies mites. Parasit Vectors (2010) 0.95
Anthelmintic activity of cyclotides: In vitro studies with canine and human hookworms. Acta Trop (2008) 0.95
Computer-aided identification of polymorphism sets diagnostic for groups of bacterial and viral genetic variants. BMC Bioinformatics (2007) 0.95
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One (2012) 0.95
High-level pyrantel resistance in the hookworm Ancylostoma caninum. Vet Parasitol (2006) 0.94
Plasmodium falciparum: new molecular targets with potential for antimalarial drug development. Expert Rev Anti Infect Ther (2009) 0.94
Assignment of Streptococcus agalactiae isolates to clonal complexes using a small set of single nucleotide polymorphisms. BMC Microbiol (2008) 0.94
Mycobacterium abscessus isolated from municipal water - a potential source of human infection. BMC Infect Dis (2013) 0.93
Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J Clin Microbiol (2006) 0.93
Longitudinal evidence of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch Dermatol (2009) 0.93
Highly discriminatory single-nucleotide polymorphism interrogation of Escherichia coli by use of allele-specific real-time PCR and eBURST analysis. Appl Environ Microbiol (2010) 0.93
Campylobacter jejuni and Campylobacter coli genotyping by high-resolution melting analysis of a flaA fragment. Appl Environ Microbiol (2009) 0.93
An improved method for undertaking limiting dilution assays for in vitro cloning of Plasmodium falciparum parasites. Malar J (2011) 0.93
The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. Diagn Microbiol Infect Dis (2012) 0.93
Antimicrobial stewardship in residential aged care facilities: need and readiness assessment. BMC Infect Dis (2014) 0.92
Interaction of Candida albicans with an intestinal pathogen, Salmonella enterica serovar Typhimurium. Eukaryot Cell (2009) 0.92
Parasitic diseases of remote Indigenous communities in Australia. Int J Parasitol (2010) 0.91
A coproantigen diagnostic test for Strongyloides infection. PLoS Negl Trop Dis (2011) 0.90
Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev Anti Infect Ther (2015) 0.89
Acetylcholine receptor subunit genes from Ancylostoma caninum: altered transcription patterns associated with pyrantel resistance. Int J Parasitol (2008) 0.89
Low-level Plasmodium falciparum blood-stage infection causes dendritic cell apoptosis and dysfunction in healthy volunteers. J Infect Dis (2012) 0.89
Statin therapy and decreased incidence of positive Candida cultures among patients with type 2 diabetes mellitus undergoing gastrointestinal surgery. Mayo Clin Proc (2010) 0.89
Modelling the dynamics of Plasmodium falciparum histidine-rich protein 2 in human malaria to better understand malaria rapid diagnostic test performance. Malar J (2012) 0.89
Antibody responses to Sarcoptes scabiei apolipoprotein in a porcine model: relevance to immunodiagnosis of recent infection. PLoS One (2013) 0.88
Aboriginal and Torres Strait Islander health research and the conduct of longitudinal studies: issues for debate. Aust N Z J Public Health (2003) 0.88
Psychiatric comorbidity and 30-day readmissions after hospitalization for heart failure, AMI, and pneumonia. Psychiatr Serv (2014) 0.87
Surveillance of infection burden in residential aged care facilities. Med J Aust (2012) 0.86